High cholesterol and hardening of the arteries remain serious threats to health in China. A group of medical experts has come together to review current practices and offer new guidance. Their goal is simple: to improve how doctors prevent and manage these conditions for people in the Chinese population. The advice focuses on initial strategies to lower cholesterol levels before they cause more damage. This guidance is meant to help healthcare providers make better choices for their patients. The experts did not report specific safety issues or side effects in this consensus statement. They also did not share exact numbers on how many people were involved or how long the review took. Instead, they focused on the overall approach to care. This update aims to fill gaps in knowledge and ensure that treatment plans fit the needs of the local community. By clarifying these steps, the group hopes to reduce heart risks and improve long-term outcomes for those living with these conditions.
Expert consensus guideline on cholesterol-lowering strategies for Chinese population with dyslipidemia and ASCVDNew guidelines offer cholesterol strategies for Chinese patients with heart disease
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider this expert consensus as guidance for initial cholesterol-lowering strategies in Chinese patients with dyslipidemia.
This document is an expert consensus guideline focused on initial cholesterol-lowering strategies for the Chinese population with dyslipidemia and atherosclerotic cardiovascular disease. The scope is to improve the prevention and management of dyslipidemia in this population. The authors synthesize expert opinion to provide practice guidance, but the guideline does not report specific pooled effect sizes, sample sizes, or primary outcome data.
The guideline does not detail a study population, intervention comparator, or adverse events, as these were not reported. The authors note that the document is a consensus, not a primary trial or systematic review, and its recommendations are based on expert synthesis rather than new trial data.
Key limitations include the lack of reported sample size, follow-up duration, and specific outcome data. The guideline's practice relevance is to inform initial strategies for dyslipidemia management in China, but its recommendations should be interpreted with caution due to the absence of reported quantitative evidence.
Clinicians should consider this guideline as one source of expert opinion for Chinese patients with dyslipidemia and ASCVD, recognizing that it does not provide new trial-level evidence.
What this means for you:
Experts in China offer new advice to better manage cholesterol and artery disease for local patients. More on Cardiovascular Disease
Multi-target therapies may address combined hypertension and dyslipidemia pathophysiology
Multi-Target Therapies May Address Combined Hypertension and High Cholesterol
This systematic review synthesizes evidence on synergistic mechanisms of hypertension and dyslipidemia, highlighting the RAAS/PPAR axis, AMP…
Combining treatments like statins and RAAS inhibitors may offer a more precise way to manage both high blood pressure and cholesterol levels…
Chronic Insomnia in Hospitalized Adults: Associated Conditions and Metabolic Abnormalities
Elderly women with insomnia often have heart disease, infections, and metabolic issues
This retrospective observational study evaluated 871 hospitalized adults aged 18 to 100 years with chronic insomnia at a single center in Ch…
Hospitalized older women with insomnia frequently face infections, heart disease, and blood sugar problems, a single-center study finds.
Review of UK Biobank data identifies plasma protein mediators in cardiometabolic disease progression
New Blood Test Clues Could Predict Diabetes Complications Years Earlier
This observational review analyzes UK Biobank data from 53,030 participants to evaluate plasma proteins as mediators in secondary disease de…
A new blood test spots specific proteins that warn of heart, kidney, and brain problems years before they happen in people with diabetes or …
Gut microbiota-derived aromatic amino acid metabolites influence myocardial injury and risk of major adverse cardiac events
Gut Microbiota Metabolites Linked to Cardiovascular Disease Risk
This systematic review synthesizes the roles of gut microbiota-derived aromatic amino acid (AAA) metabolites in cardiovascular disease. The …
Specific compounds from gut bacteria, like Phenylacetylglutamine, are linked to heart damage and increased risks for cardiovascular disease.
View Original Abstract ↓
It has been confirmed that cholesterol-lowering therapy, particularly the reduction of low-density lipoprotein cholesterol (LDL-C) levels, represents the most effective measure for decreasing the incidence of atherosclerotic cardiovascular disease and related cardiovascular events. Previous studies have shown that active reduction of cholesterol levels significantly increases the goal attainment rate of LDL-C and improves clinical outcomes. Although many cholesterol-lowering medications are currently available in clinical practice and the cholesterol lowering treatment status has improved, the real-world cholesterol management in China, especially the goal attainment rate of LDL-C, is not satisfactory. This issue is closely related to the selection of initial cholesterol-lowering treatment strategies. Furthermore, clinical research has demonstrated that the safety and adherence of cholesterol-lowering therapy are also critical factors influencing treatment effectiveness. In response, the National Cardiovascular Disease Expert Committee Cardiovascular Metabolic Medicine Professional Committee has organized domestic experts to systematically and comprehensively review methods and scientific choices for initiating cholesterol-lowering therapy in the Chinese population and developed a Chinese expert consensus on the selection of initial cholesterol-lowering strategies based on current evidence. It aims to propose optimized initial treatment regimens tailored to individual characteristics, thereby further improving the prevention and management of dyslipidemia in Chinese population.
Mazdutide monotherapy reduces HbA1c and promotes weight loss in Chinese adults with type 2 diabetes over 48 weeks
New Drug Lowers Sugar and Shrinks Weight in Diabetes
Related in Drug Pipeline
Age over 50 and alcohol use are risk factors for severe orlistat-induced liver injury
Risk Factors for Liver Injury Linked to Orlistat Use
This systematic review of case reports examines the clinical spectrum and risk factors for orlistat-induced liver injury (OILI). The analysi…
Specific risk factors like age and alcohol use may increase the chance of severe liver issues in patients taking the weight loss medication …
Berberine exhibits antimicrobial and anti-inflammatory effects for managing various oral mucosal and dental conditions
Berberine Shows Potential for Treating Various Oral Health Conditions
This systematic review synthesizes the pharmacological properties of berberine in treating oral diseases including periodontitis, caries, an…
A review of berberine suggests it may help manage oral diseases like periodontitis and dental caries through its anti-inflammatory and antio…
Intra-arterial alteplase and tenecteplase improve excellent functional outcomes after endovascular thrombectomy for stroke
Adding certain clot-busting drugs improves outcomes for stroke patients
This network meta-analysis of 2,131 patients with acute ischemic stroke caused by large-vessel occlusion found that intra-arterial thromboly…
Combining mechanical removal of blood clots with specific medications can significantly improve recovery for patients with severe strokes.
Natural compounds may alleviate anesthesia induced cognitive dysfunction through multi-target regulatory mechanisms
Natural Compounds May Help Protect Brains After Anesthesia
This systematic review evaluates 16 natural compounds, including flavonoids and polyphenols, regarding their role in mitigating anesthetic-i…
Certain natural compounds like flavonoids and polyphenols may help protect brain function from damage caused by inhalational anesthetics.
From Other Specialties
Current molecular and cellular phenotypes do not yet support clinical subtype identification for recurrent pregnancy loss
New research looks at why some pregnancies end early
This mini review examines maternal-fetal interface abnormalities in patients with unexplained recurrent pregnancy loss (URPL). The authors c…
Doctors are looking for better ways to understand and treat the reasons behind repeated pregnancy loss.
TNF inhibitors may be effective for juvenile idiopathic arthritis in patients with DiGeorge syndrome
Biologic treatments show promise for children with DiGeorge syndrome
This case report and literature review examines the management of juvenile idiopathic arthritis (JIA) in children with DiGeorge syndrome (DG…
Children with both DiGeorge syndrome and juvenile idiopathic arthritis may find relief from joint pain using specific biologic medications.
mHealth apps reduce HbA1c by 0.39% in type 2 diabetes across 19 RCTs
Mobile Health Apps Help Manage Blood Sugar in Type 2 Diabetes
This meta-analysis of 19 RCTs with 2,166 participants found that mobile health (mHealth) app interventions significantly reduced HbA1c (MD -…
Using mobile health applications can help people with type 2 diabetes lower their blood sugar levels and improve their overall quality of li…
Oral-health promotion improves outcomes for adults with type 2 diabetes when guidance is provided
Oral health care is often missed in type 2 diabetes management
This scoping review of 9 peer-reviewed studies examines oral-health promotion and prevention in adults with type 2 diabetes. The authors fin…
Many people with type 2 diabetes do not know their oral health is at risk, and doctors often provide inconsistent guidance on how to manage …